Back to Baker Bros. Advisors LP Baker Bros. Advisors LP

ZYMEZYME

Showing 0 of 16 quarters

Position history for Baker Bros. Advisors LPBaker Bros. Advisors LP's holdings in Zymeworks Inc.

As of its Q3 2022 13F, Baker Bros. Advisors held 1,708,472 shares of ZYME (Zymeworks), worth $10.5M. Baker Bros. Advisors' 13F filings listed ZYME from Q1 2019 to Q3 2022, 15 quarterly filings. ZYME was 0.1% of Baker Bros. Advisors' reported 13F portfolio.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used